Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis
Record ID 32006001045
English
Authors' objectives:
The Ontario Health Technology Advisory Committee asked the Medical Advisory Secretariat to conduct a health technology assessment on energy delivery systems for the treatment of benign prostatic hyperplasia (BPH).
Authors' recommendations:
OHTAC makes the following recommendations regarding these technologies:
Based on effectiveness, economic analysis and complication rates, it is appropriate to offer transurethral resection of the prostate (TURP), holmium laser ablation of the prostate (HoLEP), bipolar, or monopolar electrovaporization to patients for the treatment of BPH.
Informed consent for patients should include the fact that for HoLEP and bipolar electrovaporization, only 1-year follow-up is currently available, there is a slightly higher blood transfusion requirements for TURP and that TURP is associated with a small risk (0.5%) of TUR syndrome. Therefore, the choice of technique should be tailored around patient's characteristics and preferences, surgeon's experience and skills, and the availability of the technique.
OHTAC recommends that facilities providing visual laser ablation of the prostate (VLAP), contact laser vaporization (CLV), interstitial laser coagulation (ILC), transurethral microwave thermotherapy (TUMT), and transurethral needle ablation of prostate (TUNA) consider alternatives mentioned above.
OHTAC recommends that a registry study be conducted to establish longer term effectiveness and complication rates for photoselective vaporization of the prostate (PVP) given the likelihood of increasing diffusion of this technology.
Authors' methods:
Review
Details
Project Status:
Completed
Year Published:
2006
URL for published report:
http://www.health.gov.on.ca/english/providers/program/mas/tech/reviews/pdf/rev_bph_081806.pdf
URL for additional information:
http://www.hqontario.ca/en/mas/mas_ohtas_tech_bph_081806.html
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Diathermy
- Male
- Microwaves
- Prostatic Hyperplasia
Contact
Organisation Name:
Medical Advisory Secretariat
Contact Address:
Medical Advisory Secretariat, 20 Dundas Street West, 10th Floor, Toronto, ON M5G 2N6 CANADA. Tel: 416-314-1092l; Fax: 416-325-2364;
Contact Name:
MASinfo.moh@ontario.ca
Contact Email:
MASinfo.moh@ontario.ca
Copyright:
Medical Advisory Secretariat, Ontario Ministry of Health and Long-Term Care
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.